CLS is well poised for sustained growth backed by robust infrastructure investments, solid technology know-how and wide industry experience.

Barclays raised the firm’s price target on Celestica (CLS) to $157 from $139 and keeps an Overweight rating on the shares after meeting with ...

“Trump’s ambitions to scale domestic production of hi-tech goods should impact Asia economies that are major exporters of semiconductors, AI and new energy sector-related goods,” ING strategists said ...

Celestica's stock rating is adjusted from a strong buy to a buy due to a rapid share price increase and coming off seasonal strength. The CCS segment, driven by AI CapEX, is growing fast and ...

The chief executive of Celestica Inc. CLS-T, the Toronto-based technology company that came back from the dead to strike it rich off the artificial-intelligence boom, sold $130-million in common ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 150 points on Monday. Shares of Tesla, Inc TSLA fell in today's pre-market trading. Tesla CEO Elon Musk and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 30 tables and 57 figures, this 114 page report Asia Pacific Medical Device Contract Manufacturing Market 2021-2031 by ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 82 tables and 90 figures, this 169 page report Global Medical Device Contract Manufacturing Market 2021-2031 by Device ...